Tracy Lillie
Family Medicine · Huntingdon, PANPI 1689650848
Payments from drug & device makers
Across 296 payments — averaging $15.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$784
- Novo Nordisk$640
- GSK$531
- AbbVie$375
- Astellas Pharma US Inc$253
- AstraZeneca$230
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,47297%
- Education$1243%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 52 | $784 |
| Novo Nordisk | 40 | $640 |
| GSK | 40 | $531 |
| AbbVie | 18 | $375 |
| Astellas Pharma US Inc | 12 | $253 |
| AstraZeneca | 15 | $230 |
| Novartis | 17 | $227 |
| Boehringer Ingelheim | 12 | $178 |
| Pfizer | 11 | $156 |
| Johnson & Johnson | 16 | $155 |
| Sanofi-aventis U.S. LLC | 8 | $118 |
| E.r. Squibb & Sons, L.L.C. | 8 | $118 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $97 |
| Daiichi Sankyo Inc. | 4 | $85 |
| Corcept Therapeutics | 4 | $77 |
| Biohaven Pharmaceuticals, Inc. | 3 | $73 |
| Phathom Pharmaceuticals, Inc. | 3 | $65 |
| Nevro Corp. | 2 | $62 |
| Abbott | 3 | $57 |
| Merck | 4 | $54 |
| Amgen | 3 | $54 |
| Exact Sciences | 3 | $50 |
| Amarin Pharma, Inc. | 3 | $46 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $22 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Philips North America LLC | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOUNJARO$100
How this compares
$4,596 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 77 | $82,175 |
| MounjaroTirzepatide | 32 | $46,686 |
| EliquisApixaban | 49 | $42,745 |
| XareltoRivaroxaban | 29 | $40,624 |
| JardianceEmpagliflozin | 35 | $39,724 |
| FarxigaDapagliflozin Propanediol | 28 | $25,370 |
| JanuviaSitagliptin Phosphate | 26 | $24,695 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 14 | $20,944 |
| Breo ElliptaFluticasone/Vilanterol | 32 | $18,436 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 33 | $14,899 |
| MyrbetriqMirabegron | 22 | $14,124 |
| EntrestoSacubitril/Valsartan | 27 | $13,904 |
| OzempicSemaglutide | 12 | $11,140 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $11,062 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $9,001 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $784 | $128,861109 claims |
| PfizerEliquis | $156 | $42,74549 claims |
| Johnson & JohnsonXarelto | $155 | $40,62429 claims |
| Boehringer IngelheimJardiance | $178 | $39,72435 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Anoro Ellipta | $531 | $38,49968 claims |
| AstraZenecaFarxiga | $230 | $25,37028 claims |
| MerckJanuvia | $54 | $24,69526 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $118 | $20,94414 claims |
| Astellas Pharma US IncMyrbetriq | $253 | $14,12422 claims |
| NovartisEntresto | $227 | $13,90427 claims |
| Novo NordiskOzempic | $640 | $11,14012 claims |
| AbbVieSynthroid | $375 | $1,95852 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Huntingdon
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.